February 13, 2025 10:37 AM EST
Deals

Idor­sia’s Tryvio li­cens­ing ne­go­ti­a­tions col­lapse amid cash squeeze

Ayisha Sharma

News Reporter

Idor­sia’s plan to hand over the glob­al rights to its blood pres­sure drug Tryvio has end­ed in dis­ap­point­ment af­ter a deal an­nounced in No­vem­ber fell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Kennedy is con­firmed to lead HHS, putting an­ti-vac­cine ad­vo­cate and drug in­dus­try skep­tic atop US health ...

Neumo­ra shakes up C-suite a month af­ter de­pres­sion drug fails first Phase 3 tri­al

David Bak­er's lab makes en­zymes with AI, open­ing up the pos­si­bil­i­ty of more pre­cise gene-edit­ing tools

Af­ter help­ing build Al­phaFold, a 34-year-old first-time CEO launch­es his own AI biotech with $50M

Agios’ Pyrukynd suc­ceeds in key tri­al of rare red blood cell dis­or­der in kids

sponsored

Re­duc­ing risk in drug de­vel­op­ment: The im­por­tance of val­i­dat­ed MRD test­ing in lym­phoid can­cers

A service from the Financial Times